• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人泪液乳铁蛋白浓度与眼部疾病:一项荟萃分析。

Lactoferrin Concentration in Human Tears and Ocular Diseases: A Meta-Analysis.

机构信息

University of Milano Bicocca, Materials Science Department, Milan, Italy.

University of Eastern Piedmont, Department of Translational Medicine, Novara, Italy.

出版信息

Invest Ophthalmol Vis Sci. 2020 Oct 1;61(12):9. doi: 10.1167/iovs.61.12.9.

DOI:10.1167/iovs.61.12.9
PMID:33035290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7552940/
Abstract

PURPOSE

To evaluate the potential of lactoferrin (Lf) as a diagnostic biomarker for ocular diseases using a meta-analytic approach.

METHODS

All original studies reporting an estimate of the average Lf concentration in healthy subjects and those affected by ocular diseases were searched up to March 2020. The DerSimonian and Laird method was used to calculate the random effects pooled mean difference and the corresponding 95% confidence interval (CI) in Lf concentration between healthy subjects and those affected by dry eye (DE), Sjögren syndrome (SS), and diabetic retinopathy, separately. The presence of between-study heterogeneity was evaluated using the Cochran's Q test and the I2 index. Stratified analyses were performed to assess potential sources of heterogeneity and influence and cumulative analyses to evaluate the robustness of the results obtained. Publication bias was also evaluated using funnel plot and the Egger's test.

RESULTS

The pooled mean differences in Lf concentrations between healthy subjects and those with DE, Sjögren syndrome, and diabetic retinopathy were respectively 0.62 (95% CI, 0.35-0.89) for DE, 3.78 (95% CI, -6.64 to 14.17), and 0.19 (95% CI, -4.00 to 4.39). Regarding DE, the stratified analysis showed that geographical area (P value Q test < 0.0001) and sample size (P < 0.0005) were sources of heterogeneity. Moreover, no study substantially influenced the results obtained and the pooled mean difference became statistically significant after a sample size of 220. Publication bias may affect the results of DE.

CONCLUSIONS

The results of the current meta-analysis suggest that Lf level in tears is a good candidate as dry eye syndrome diagnostic biomarker.

摘要

目的

采用荟萃分析方法评估乳铁蛋白(Lf)作为眼部疾病诊断生物标志物的潜力。

方法

检索至 2020 年 3 月,所有报告健康受试者和眼部疾病患者Lf 平均浓度估计值的原始研究均被纳入。采用 DerSimonian 和 Laird 法计算健康受试者与干眼症(DE)、干燥综合征(SS)和糖尿病性视网膜病变患者之间Lf 浓度的随机效应汇总均数差值及其相应的 95%置信区间(CI)。采用 Cochran's Q 检验和 I2 指数评估研究间异质性。进行分层分析以评估潜在的异质性来源和影响,以及累积分析以评估获得结果的稳健性。还采用漏斗图和 Egger 检验评估发表偏倚。

结果

健康受试者与 DE、SS 和糖尿病性视网膜病变患者之间 Lf 浓度的汇总均数差值分别为 0.62(95%CI,0.35-0.89)、3.78(95%CI,-6.64 至 14.17)和 0.19(95%CI,-4.00 至 4.39)。对于 DE,分层分析表明地理区域(P 值 Q 检验<0.0001)和样本量(P<0.0005)是异质性的来源。此外,没有研究显著影响获得的结果,并且在样本量达到 220 后,汇总均数差值变得具有统计学意义。发表偏倚可能影响 DE 的结果。

结论

当前荟萃分析的结果表明,泪液中的 Lf 水平是干燥综合征诊断生物标志物的良好候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/91ce4183b28b/iovs-61-12-9-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/253c263b7e03/iovs-61-12-9-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/062041bd3c7c/iovs-61-12-9-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/f9976c62645b/iovs-61-12-9-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/b3e763500240/iovs-61-12-9-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/79d783efe953/iovs-61-12-9-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/2343b7e750be/iovs-61-12-9-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/91ce4183b28b/iovs-61-12-9-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/253c263b7e03/iovs-61-12-9-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/062041bd3c7c/iovs-61-12-9-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/f9976c62645b/iovs-61-12-9-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/b3e763500240/iovs-61-12-9-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/79d783efe953/iovs-61-12-9-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/2343b7e750be/iovs-61-12-9-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18e8/7552940/91ce4183b28b/iovs-61-12-9-f007.jpg

相似文献

1
Lactoferrin Concentration in Human Tears and Ocular Diseases: A Meta-Analysis.人泪液乳铁蛋白浓度与眼部疾病:一项荟萃分析。
Invest Ophthalmol Vis Sci. 2020 Oct 1;61(12):9. doi: 10.1167/iovs.61.12.9.
2
Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.泪液蛋白质组学在监测干燥综合征或干眼疾病中的应用。
Int J Mol Sci. 2019 Apr 19;20(8):1932. doi: 10.3390/ijms20081932.
3
Fluorescence-based reagent and spectrum-based optical reader for lactoferrin detection in tears: differentiating Sjögren's syndrome from non-Sjögren's dry eye syndrome.基于荧光的试剂和基于光谱的光学读取器用于检测泪液中的乳铁蛋白:区分干燥综合征和非干燥综合征的干眼症。
Sci Rep. 2024 Jun 24;14(1):14505. doi: 10.1038/s41598-024-65487-2.
4
Abnormal protein profiles in tears with dry eye syndrome.干眼症患者泪液中的异常蛋白质谱。
Am J Ophthalmol. 2003 Aug;136(2):291-9. doi: 10.1016/s0002-9394(03)00203-4.
5
Ocular surface damage and tear lactoferrin in dry eye syndrome.干眼综合征中的眼表损伤与泪液乳铁蛋白
Acta Ophthalmol (Copenh). 1994 Aug;72(4):433-7. doi: 10.1111/j.1755-3768.1994.tb02791.x.
6
Tear lipocalin, lysozyme and lactoferrin concentrations in postmenopausal women.绝经后女性泪液中视黄醇结合蛋白、溶菌酶和乳铁蛋白的浓度
J Med Life. 2015;8 Spec Issue(Spec Issue):94-8.
7
The ratio of albumin to lactoferrin in tear fluid as a diagnostic tool in primary Sjögren's syndrome.泪液中白蛋白与乳铁蛋白的比值作为原发性干燥综合征的诊断工具。
Acta Ophthalmol Scand. 1997 Oct;75(5):507-11. doi: 10.1111/j.1600-0420.1997.tb00138.x.
8
Lactoferrin and Its Detection Methods: A Review.乳铁蛋白及其检测方法综述。
Nutrients. 2021 Jul 22;13(8):2492. doi: 10.3390/nu13082492.
9
Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome.干眼症患者泪液中白细胞介素-6和肿瘤坏死因子-α水平
Cornea. 2007 May;26(4):431-7. doi: 10.1097/ICO.0b013e31803dcda2.
10
Comparison of Meibomian Gland Imaging Findings and Lipid Layer Thickness between Primary Sjögren Syndrome and Non-Sjögren Syndrome Dry Eyes.原发性干燥综合征与非干燥综合征干眼的睑板腺成像结果与脂质层厚度比较。
Ocul Immunol Inflamm. 2020;28(2):182-187. doi: 10.1080/09273948.2018.1562557. Epub 2019 Feb 22.

引用本文的文献

1
Tear-fluid-derived biomarkers of ocular complications in diabetes: a systematic review and meta-analysis.糖尿病眼部并发症的泪液衍生生物标志物:系统评价与荟萃分析。
BMC Med. 2025 Feb 12;23(1):84. doi: 10.1186/s12916-025-03855-z.
2
Lactoferrin as a Versatile Agent in Nanoparticle Applications: From Therapeutics to Agriculture.乳铁蛋白作为纳米颗粒应用中的多功能剂:从治疗到农业。
Nanomaterials (Basel). 2024 Dec 16;14(24):2018. doi: 10.3390/nano14242018.
3
Global research hotspots and trends in anti-inflammatory studies in dry eye: a bibliometric analysis (2004-2024).

本文引用的文献

1
Review of Biomarkers in Ocular Matrices: Challenges and Opportunities.眼基质生物标志物的研究:挑战与机遇
Pharm Res. 2019 Jan 23;36(3):40. doi: 10.1007/s11095-019-2569-8.
2
Definition and Diagnostic Criteria of Dry Eye Disease: Historical Overview and Future Directions.干眼定义和诊断标准:历史回顾与未来方向。
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES7-DES12. doi: 10.1167/iovs.17-23475.
3
A novel and innovative paper-based analytical device for assessing tear lactoferrin of dry eye patients.一种新颖创新的基于纸张的分析装置,用于评估干眼症患者的泪液乳铁蛋白。
干眼抗炎研究的全球研究热点与趋势:文献计量分析(2004 - 2024年)
Front Med (Lausanne). 2024 Nov 28;11:1451990. doi: 10.3389/fmed.2024.1451990. eCollection 2024.
4
Four-Week GLP Immunotoxicity Assessment of Lactoferrin Alpha Produced by in Sprague-Dawley Rats.在Sprague-Dawley大鼠中进行的乳铁蛋白α四周GLP免疫毒性评估。
Int J Toxicol. 2025 Mar-Apr;44(2):125-140. doi: 10.1177/10915818241299344. Epub 2024 Nov 13.
5
Tear-Based Ocular Wearable Biosensors for Human Health Monitoring.基于泪液的眼部可穿戴生物传感器用于人体健康监测。
Biosensors (Basel). 2024 Oct 8;14(10):483. doi: 10.3390/bios14100483.
6
A Review of the Tear Film Biomarkers Used to Diagnose Sjogren's Syndrome.《用于诊断干燥综合征的泪膜生物标志物的研究进展》。
Int J Mol Sci. 2024 Sep 26;25(19):10380. doi: 10.3390/ijms251910380.
7
TACSTD2 in gelatinous drop-like corneal dystrophy: variant functional analysis and expression in the cornea after limbal stem cell transplantation.TACSTD2在胶滴状角膜营养不良中的作用:变异体功能分析及角膜缘干细胞移植后在角膜中的表达
Hum Genome Var. 2024 Jul 16;11(1):26. doi: 10.1038/s41439-024-00284-x.
8
Development, Optimization, and Clinical Relevance of Lactoferrin Delivery Systems: A Focus on Ocular Delivery.乳铁蛋白递送系统的开发、优化及临床相关性:聚焦眼部递送
Pharmaceutics. 2024 Jun 14;16(6):804. doi: 10.3390/pharmaceutics16060804.
9
Recommendations for nutritional supplements for dry eye disease: current advances.干眼症营养补充剂的建议:当前进展
Front Pharmacol. 2024 May 30;15:1388787. doi: 10.3389/fphar.2024.1388787. eCollection 2024.
10
Is there a relationship between the severity of disease in major depressive disorder patients and dry eye disease?在重度抑郁症患者中,疾病的严重程度与干眼症之间是否存在关系?
Int Ophthalmol. 2024 Mar 29;44(1):163. doi: 10.1007/s10792-024-03050-8.
Ocul Surf. 2019 Jan;17(1):160-166. doi: 10.1016/j.jtos.2018.11.001. Epub 2018 Nov 3.
4
Lactoferrin level in breast milk: a study of 248 samples from eight regions in China.母乳中乳铁蛋白水平:来自中国 8 个地区的 248 个样本研究。
Food Funct. 2018 Aug 15;9(8):4216-4222. doi: 10.1039/c7fo01559c.
5
Dry eye disease and oxidative stress.干眼症与氧化应激。
Acta Ophthalmol. 2018 Jun;96(4):e412-e420. doi: 10.1111/aos.13526. Epub 2017 Aug 21.
6
TFOS DEWS II Diagnostic Methodology report.TFOS DEWS II 诊断方法学报告。
Ocul Surf. 2017 Jul;15(3):539-574. doi: 10.1016/j.jtos.2017.05.001. Epub 2017 Jul 20.
7
TFOS DEWS II Definition and Classification Report.TFOS DEWS II 定义与分类报告。
Ocul Surf. 2017 Jul;15(3):276-283. doi: 10.1016/j.jtos.2017.05.008. Epub 2017 Jul 20.
8
Foreword: Biomarkers and Surrogate Endpoints in Ophthalmic Clinical Research.前言:眼科临床研究中的生物标志物与替代终点
Invest Ophthalmol Vis Sci. 2017 May 1;58(6):BIOi-BIOii. doi: 10.1167/iovs.17-22128.
9
Angiogenin for the Diagnosis and Grading of Dry Eye Syndrome.血管生成素用于干眼症综合征的诊断和分级
Korean J Ophthalmol. 2016 Jun;30(3):163-71. doi: 10.3341/kjo.2016.30.3.163. Epub 2016 May 18.
10
Issues in biomarker identification, validation and development for disease diagnostics in Public Health.公共卫生领域疾病诊断中生物标志物识别、验证与开发的相关问题。
Expert Rev Mol Diagn. 2016;16(4):383-6. doi: 10.1586/14737159.2016.1133300. Epub 2016 Jan 22.